GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists-Reference-Cited by-同舟云学术

GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists

Published:2013-11-20 Issue:2 Volume:23 Page:243-254
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Moskal Joseph R,Burch Ronald,Burgdorf Jeffrey S,Kroes Roger A,Stanton Patric K,Disterhoft John F,Leander J David

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/13543784.2014.852536

Reference79 articles.

1. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

2. Glutamate Receptor Ion Channels: Structure, Regulation, and Function

3. Regional and developmental heterogeneity in splicing of the rat brain NMDAR1 mRNA

4. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

5. Developmental changes in distribution of NMDA receptor channel subunit mRNAs

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel NMDA receptor modulator: the antidepressant effect and mechanism of GW043;CNS Neuroscience & Therapeutics;2024-02

2. Targeting metaplasticity mechanisms to promote sustained antidepressant actions;Molecular Psychiatry;2024-01-04

3. Reply to commentaries – the separation distress hypothesis of depression – an update and systematic review;Neuropsychoanalysis;2024-01-02

4. The role of N-methyl-D-aspartate glutamate receptors in Alzheimer’s disease: From pathophysiology to therapeutic approaches;Progress in Neurobiology;2023-12

5. Unraveling the roots of depression – it’s complicated;Neuropsychoanalysis;2023-07-03